UiPath (NYSE:PATH) Given Hold Rating at Needham & Company LLC

Needham & Company LLC reissued their hold rating on shares of UiPath (NYSE:PATH) in a research note published on Friday, Benzinga reports.

A number of other analysts also recently weighed in on the stock. Truist Financial reissued a hold rating and set a $14.00 price target (down previously from $32.00) on shares of UiPath in a research report on Thursday, May 30th. Evercore ISI reduced their price objective on UiPath from $27.00 to $13.00 and set an in-line rating on the stock in a research note on Thursday, May 30th. KeyCorp reiterated a sector weight rating on shares of UiPath in a research note on Thursday, May 30th. Bank of America lifted their price objective on shares of UiPath from $16.00 to $18.00 and gave the company a neutral rating in a research note on Friday. Finally, JPMorgan Chase & Co. cut their price objective on shares of UiPath from $28.00 to $19.00 and set an overweight rating on the stock in a research note on Thursday, May 30th. Sixteen investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of Hold and an average target price of $17.71.

UiPath Stock Up 1.8 %

Shares of NYSE:PATH opened at $12.19 on Friday. UiPath has a 52-week low of $10.37 and a 52-week high of $27.87. The company has a 50 day moving average of $12.19 and a two-hundred day moving average of $16.54. The company has a market capitalization of $6.98 billion, a price-to-earnings ratio of -76.19 and a beta of 0.87.

UiPath (NYSE:PATH) last released its quarterly earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.89%. The business had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. During the same quarter last year, the company earned ($0.09) earnings per share. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. On average, equities analysts anticipate that UiPath will post -0.22 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Mark Sheptoff Financial Planning LLC acquired a new position in UiPath during the fourth quarter worth about $25,000. ORG Partners LLC increased its stake in UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after purchasing an additional 1,112 shares in the last quarter. Hantz Financial Services Inc. purchased a new position in UiPath in the 2nd quarter worth about $28,000. Redwood Wealth Management Group LLC purchased a new position in UiPath in the 2nd quarter worth about $43,000. Finally, Lindbrook Capital LLC increased its stake in UiPath by 46.0% in the 1st quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock worth $46,000 after purchasing an additional 639 shares in the last quarter. 62.50% of the stock is owned by institutional investors and hedge funds.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.